Neurana Pharmaceuticals


Neurana Pharmaceuticals is a privately-held clinical-stage San Diego-based specialty pharmaceutical company developing a novel treatment for acute muscle spasms. The Company was founded in 2013 to focus on central nervous system (CNS) diseases and disorders.

Industries

Employees

11-50

Links


Org chart

Craig Thompson
President & CEO
Collapse
Randall Kaye
Chief Medical Officer
Kathy Scott
Chief Financial Officer
Johnna Simões
Head, Corporate Development
Jim Gallagher
Senior Director of CMC, Manufacturing

Board & advisors



Offices